New in the description of anaplastic lymphoma on breast implants!
Publication in the January issue of the journal Blood of an article co-authored by members of Nicolas Ortonne’s team in collaboration with teams from Toulouse, among others, describing for the first time the mutational landscape – notably involving activation of the JAK-STAT pathway and disruption of the epigenetic – of a new form of lymphoma, recognized by the FDA in 2010, anaplastic lymphoma on breast implants (breast prostheses).
Blood, January 30, 2020, Vol 135, No. 5, pages 360-370.
For more information : Philippe Gaulard
Incoming seminars
When Chemistry Meets Health – 3rd IMRB/ICMPE Seminar: Anticancer Therapy: Use of a Multivalent Nucleolin Antagonist in Free or Polyplexed Form :
«3rd IMRB/ICMPE Seminar - Ilaria CASCONE et Jacques PENELLE - De 11h30 à 13h – Webconférence Zoom»
The Adhesion GPCR Gpr116 Maintains the MuSC Pool via Nuclear Activities of beta-arrestin1 :
«Colin CRIST - 12h – Amphi 5 (sous-réserve), 4ème étage de la Faculté de Santé de Créteil»
Dysfonctions neurocognitives dans le trouble bipolaire et innovations thérapeutiques personnalisées :
«Pauline FAVRE - 13h - Webconférence Zoom»
All incoming seminars
